Sanofi ends patent dispute with Barr, Teva over allergy drugs
Sanofi-Aventis agreed to resolve patent litigation in the U.S. against Barr Pharmaceuticals and Teva Pharmaceutical Industries over their copies of allergy medicines Nasacort and Allegra. Under the settlement, Sanofi will receive royalty fees in exchange for giving the generic-drug makers nonexclusive licenses to market their versions.
Reuters | 11/19
This story published in FMI Pharmacy dailyLead on 11/20/2008
More from SmartBrief:
Teva introduces generic copy of chemo treatment Eloxatin
Wednesday, August 12, 2009
FDA approves Plan B One-Step birth control pill
Tuesday, July 14, 2009
Generics firms oppose higher rebates in Sen. Baucus' health bill
Friday, September 18, 2009
Get stories like these delivered daily for FREE:
|
FMI Pharmacy dailyLead
Designed specifically for pharmacy professionals, FMI Pharmacy dailyLead is a FREE, daily e-mail newsletter. It provides the latest news in the pharmacy arena. Learn more |
|